Jianjun Cheng

Champaign, IL, United States of America

Jianjun Cheng

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 247(Granted Patents)


Location History:

  • Urbana, IL (US) (2018)
  • Chicago, IL (US) (2019)
  • Champaign, IL (US) (2014 - 2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: **Jianjun Cheng: Innovator in Patent Development and Cancer Research**

Introduction

Jianjun Cheng is a prominent inventor based in Champaign, IL, recognized for his groundbreaking contributions to the fields of chemistry and biomedical engineering. With a total of 22 patents to his name, his innovations focus on enhancing the effectiveness of various substances, particularly in the realm of cancer treatment and detergent applications.

Latest Patents

Cheng's recent patents demonstrate his focus on developing advanced solutions. One notable patent is for "Tetraacetyldiamine and triacetyldiamine derivatives useful as bleach activators." This invention relates to bleach activator compositions, featuring tetraacetyldiamine and triacetyldiamine derivatives. These compounds serve as effective bleach activators, showcasing their potential application in detergents or biocides.

Another significant patent involves "Trigger-activatable sugar conjugates for cancer-selective labeling and targeting." This innovation introduces compounds designed for the selective labeling of cell-surface sugars in cancer cells. Activated by triggers specific to cancer cells, these compounds label the surface sugar with an azide chemical group, allowing for targeted drug delivery while minimizing toxicity. It illustrates Cheng’s dedication to enhancing cancer treatment methodologies.

Career Highlights

Cheng has made significant contributions within esteemed institutions, including the University of Illinois and the Massachusetts Institute of Technology (MIT). His time at these institutions has facilitated expansive research opportunities that culminated in numerous patents and innovative solutions directed towards chemical and biomedical applications.

Collaborations

Throughout his career, Cheng has collaborated with notable figures in his field, including Hanze Ying and Robert S. Langer. These partnerships have contributed significantly to the collective advancement of research, particularly in the realms of drug delivery systems and targeted cancer therapies.

Conclusion

Jianjun Cheng continues to be an influential figure in innovation, particularly in regard to cancer research and chemical applications. His extensive patent portfolio not only showcases his inventive spirit but also his commitment to enhancing both everyday consumer products and critical medical treatments. As he advances further in his career, the impact of his work will undoubtedly continue to resonate across various fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…